POLI, GUIDO
 Distribuzione geografica
Continente #
AS - Asia 4.017
NA - Nord America 3.326
EU - Europa 1.812
SA - Sud America 1.205
AF - Africa 95
OC - Oceania 7
Totale 10.462
Nazione #
US - Stati Uniti d'America 3.218
SG - Singapore 1.714
CN - Cina 1.061
BR - Brasile 1.031
HK - Hong Kong 624
SE - Svezia 595
RO - Romania 267
VN - Vietnam 264
RU - Federazione Russa 212
IT - Italia 206
DE - Germania 151
FI - Finlandia 81
IN - India 72
GB - Regno Unito 67
AR - Argentina 66
IE - Irlanda 54
BD - Bangladesh 48
CA - Canada 48
ID - Indonesia 41
EC - Ecuador 39
MX - Messico 39
ZA - Sudafrica 37
FR - Francia 34
AT - Austria 31
JP - Giappone 26
IQ - Iraq 25
PL - Polonia 25
TR - Turchia 24
NL - Olanda 23
ES - Italia 21
MA - Marocco 17
PY - Paraguay 16
UA - Ucraina 15
UZ - Uzbekistan 15
VE - Venezuela 14
CO - Colombia 13
PK - Pakistan 13
MY - Malesia 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
SA - Arabia Saudita 10
TW - Taiwan 9
CL - Cile 8
JM - Giamaica 7
PE - Perù 7
UY - Uruguay 7
AU - Australia 6
IL - Israele 6
KE - Kenya 6
KZ - Kazakistan 6
DZ - Algeria 5
IR - Iran 5
LT - Lituania 5
CR - Costa Rica 4
GA - Gabon 4
PH - Filippine 4
UG - Uganda 4
AL - Albania 3
AM - Armenia 3
AZ - Azerbaigian 3
BE - Belgio 3
BO - Bolivia 3
BY - Bielorussia 3
LB - Libano 3
NG - Nigeria 3
NP - Nepal 3
SN - Senegal 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
JO - Giordania 2
KR - Corea 2
LV - Lettonia 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ET - Etiopia 1
GI - Gibilterra 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ML - Mali 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
Totale 10.458
Città #
Dallas 1.488
Singapore 651
Hong Kong 622
Ashburn 298
Shanghai 262
Hefei 254
Lawrence 230
Princeton 230
Ho Chi Minh City 102
Beijing 85
New York 82
São Paulo 79
Los Angeles 66
Helsinki 61
Milan 57
Hanoi 52
Moscow 52
Dublin 50
The Dalles 46
Nuremberg 35
Belo Horizonte 31
Pune 31
Boardman 30
Denver 30
Munich 30
Washington 30
Columbus 28
Brasília 27
Rio de Janeiro 26
Tokyo 26
Guangzhou 25
Montreal 24
Warsaw 22
Stockholm 21
Curitiba 20
Seattle 20
Orem 19
Santa Clara 19
Haiphong 18
Brooklyn 17
Chicago 17
Poplar 17
Turku 17
Chennai 16
Houston 16
Guayaquil 15
Tashkent 15
Porto Alegre 14
Johannesburg 13
Mexico City 13
Rome 13
Salvador 13
Xi'an 13
Amsterdam 11
Dhaka 11
Jakarta 11
Kuala Lumpur 11
Ribeirão Preto 11
Vienna 11
Ankara 10
Atlanta 10
Baghdad 10
Boston 10
Campinas 10
Council Bluffs 10
Guarulhos 10
London 10
Tianjin 10
Buenos Aires 9
Caxias do Sul 9
Fortaleza 9
Toronto 9
Cape Town 8
Charlotte 8
Hải Dương 8
Joinville 8
Juiz de Fora 8
Kassel 8
Manaus 8
Peschiera Borromeo 8
Quito 8
Shenzhen 8
Biên Hòa 7
Casablanca 7
Frankfurt am Main 7
Jeddah 7
Lima 7
Montevideo 7
Osasco 7
Santo André 7
Zhengzhou 7
Cairo 6
Caruaru 6
Fuzhou 6
Hangzhou 6
Manchester 6
Pelotas 6
Petrolina 6
Phoenix 6
Sapiranga 6
Totale 5.877
Nome #
1,25-dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-Kappa B-independent enhancement of viral replication 1.390
Origin and evolution of SARS-CoV-2 109
5-Hydroxytyrosol inhibits HIV-1 replication in primary cells of the lower and upper female reproductive tract 99
Biobanking for COVID-19 research 86
Modulation of NBAS-Related Functions in the Early Response to SARS-CoV-2 Infection 81
ACTIVATED LYMPHOCYTES-B FROM HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INDIVIDUALS INDUCE VIRUS EXPRESSION IN INFECTED T-CELLS AND A PROMONOCYTIC CELL-LINE, U1 80
Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4) 78
Editorial: New frontiers in HIV antiretroviral treatment: from the management of metabolic complications and chronic inflammation to new long-acting regimens 77
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 77
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 75
M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication. 73
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity 72
In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. 69
A PLATELET-ACTIVATING-FACTOR ANTAGONIST, RP-55778, INHIBITS CYTOKINE-DEPENDENT INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION IN CHRONICALLY INFECTED PROMONOCYTIC CELLS 69
Association between the presence of CCR5-specific antibodies and long term non progression 68
Candidate Microbicide 5-hydroxytyrosol (5-HT) Inhibits Productive R5 HIV-1 Infection of Human Cervical Tissue Explants (CTE). 68
An approach to HIV gene therapy by transduction of multifunctional retroviral vectors in primary human T Lymphocytes 66
ALPHA-INTERFERON SUPPRESSES VIRION BUT NOT SOLUBLE HUMAN-IMMUNODEFICIENCY-VIRUS ANTIGEN PRODUCTION IN CHRONICALLY INFECTED T-LYMPHOCYTIC CELLS 66
Heparin Protects Human Neural Progenitor Cells from Zika Virus-Induced Cell Death While Preserving Their Differentiation into Mature Neuroglial Cells 64
A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTIC CELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS 64
Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls 62
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 61
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 59
Restriction of Zika Virus Replication in Human Monocyte-Derived Macrophages by Pro-Inflammatory (M1) Polarization 58
A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1 58
[Transitory increase of OKT4+ lymphocytes in the peripheral blood of patients with lymphadenopathy syndrome treated with beta-interferon]. FT Incremento transitorio dei linfociti OKT4+ in sangue periferico di pazienti affetti da LAS trattati con IFN-beta. 57
Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load (Nature, (2023), 620, 7976, (1025-1030), 10.1038/s41586-023-06370-4) 56
Asymmetric HIV-1 co-receptor use and replication in CD4+ T lymphocytes 55
Amotosalen Photochemical Inactivation of Severe Acute Respiratory Syndrome CoronaVirus (SARS-CoV) in Human Platelet Concentrates 55
The Long and Winding Road towards an HIV Cure 54
TRIM22. A multitasking antiviral factor 52
Preface 51
Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer 51
Retroviruses and opportunistic infections--eighth annual conference--structured therapy interruption. 51
Coronaviridae and SARS-associated coronavirus strain HSR1 51
Preface 50
Zika Virus: a re-emerging pathogen with rapidly evolving public health implications 50
Post-entry events of efficient R5 vs. inefficient X4 HIV-1 replication in primary CD4+T lymphocytes, a transcriptome analysis 49
Heparin Precursors with Reduced Anticoagulant Properties Retain Antiviral and Protective Effects That Potentiate the Efficacy of Sofosbuvir against Zika Virus Infection in Human Neural Progenitor Cells 48
Africa-specific human genetic variation near CHD1L associates with HIV-1 load 48
Erratum: Correction for Kajaste-Rudnitski et al., "TRIM22 Inhibits HIV-1 Transcription Independently of Its E3 Ubiquitin Ligase Activity, Tat, and NF-κB-Responsive Long Terminal Repeat Elements" (Journal of virology (2011) 85 10 DOI: 10.1128/JVI.02302-10.) 48
Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication 48
Vinegar and its active component acetic acid inhibit SARS-CoV-2 infection in vitro and ex vivo 48
M1 and M2a Polarization of Human Monocyte-Derived Macrophages Inhibits HIV-1 Replication by Distinct Mechanisms 47
Laureate ESCI award for excellence in clinical science 1999: cytokines and the human immunodeficiency virus: from bench to bedside 46
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines 46
Macrophage polarization and HIV-1 infection 45
Engagement of CD30 shapes the secretion of cytokines by human gamma delta T cells 45
Mononuclear phagocytes and HIV infection 45
INTERFERON-GAMMA INDUCES THE EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERSISTENTLY INFECTED PROMONOCYTIC CELLS (U1) AND REDIRECTS THE PRODUCTION OF VIRIONS TO INTRACYTOPLASMIC VACUOLES IN PHORBOL-MYRISTATE ACETATE DIFFERENTIATED U1 CELLS 45
Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus 45
IMMUNOPATHOGENIC MECHANISMS IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION 45
Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells 44
Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy 44
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands 44
Chronically infected T-cell lines become handy for a novel assay measuring the reservoir of replication-competent HIV-1 44
Preparing for phase II/III HIV vaccine trials in Africa 43
Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection 43
Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1CD4(+) T cells 43
Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease 42
Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection 42
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. 42
Bacterial toxins: Potential weapons against HIV infection 42
Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives 41
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. 41
Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells 41
Highlights of the 9th edition of the Conference on HIV Persistence During Therapy, 10-13 December 2019, Miami, USA 41
FP-21399 (Lexigen Pharmaceuticals). 40
PRO-140 (Progenics). 40
INTERFERONS IN THE PATHOGENESIS AND TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION 39
Human Monocyte-Derived Macrophages (MDM): Model 2 38
The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages 38
Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection 38
Long-lasting CCR5 internalization by antibodies in a subset of long-term non progressors: a possible protective effect against disease progression 38
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells 38
N-acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently infected cells. 38
The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection 37
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 37
CYTOKINES IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND OTHER INFECTIOUS-DISEASES 37
HIV REPLICATION IN IL-2-STIMULATED PERIPHERAL-BLOOD MONONUCLEAR-CELLS IS DRIVEN IN AN AUTOCRINE PARACRINE MANNER BY ENDOGENOUS CYTOKINES 37
Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat 37
Jurkat-Derived (J-Lat, J1.1, and Jurkat E4) and CEM-Derived T Cell Lines (8E5 and ACH-2) as Models of Reversible Proviral Latency 36
Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein 36
Role of cytokines and chemokines in the regulation of innate immunity and HIV infection 36
CYTOKINE-MEDIATED INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) EXPRESSION AND CELL-DEATH IN CHRONICALLY INFECTED U1 CELLS - DO TUMOR-NECROSIS-FACTOR-ALPHA AND GAMMA-INTERFERON SELECTIVELY KILL HIV-INFECTED CELLS 36
RECOMBINANT GP120 SPECIFICALLY ENHANCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND IG SECRETION IN LYMPHOCYTES-B FROM HIV-INFECTED INDIVIDUALS BUT NOT FROM SERONEGATIVE DONORS 36
THE EFFECT OF CYTOKINES AND PHARMACOLOGICAL AGENTS ON CHRONIC HIV-INFECTION 36
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells 36
Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors: Possible protective effect of infecting HCV genotype on HIV disease progression 36
U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral Latency 35
INTERLEUKIN-1 INDUCES EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ALONE AND IN SYNERGY WITH INTERLEUKIN-6 IN CHRONICALLY INFECTED U1 CELLS - INHIBITION OF INDUCTIVE EFFECTS BY THE INTERLEUKIN-1 RECEPTOR ANTAGONIST 35
IMMUNOPATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION 35
Experiences in immune reconstitution. The rationale for interleukin-2 administration to HIV-infected individuals 35
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. 35
HIV-1 envelope-dependent restriction of CXCR4-using viruses in child but not adult untransformed CD4+ T-lymphocyte lines 35
MCP-1 and CCR2 in HIV infection: Regulation of agonist and receptor expression 34
ULTRAVIOLET-IRRADIATION AND CYTOKINES AS REGULATORS OF HIV LATENCY AND EXPRESSION 34
Highlights from the Seventh International Workshop on HIV Persistence during Therapy, 8-11 December 2015, Miami, Florida, USA 34
Vaccine adjuvants: A priority for vaccine research 34
Deficient natural-cell mediated immunity against "Salmonella typhi" in patients with LAS and AIDS. 34
Totale 6.297
Categoria #
all - tutte 88.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.633


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 2 0 0 0 0 0 0
2021/2022110 0 0 0 59 16 3 4 5 1 3 3 16
2022/20231.177 542 237 95 8 10 108 56 57 25 4 30 5
2023/2024485 7 26 64 25 37 138 22 38 4 28 28 68
2024/20253.345 386 44 65 90 81 266 645 232 526 534 240 236
2025/20265.408 705 1.071 1.536 1.352 550 194 0 0 0 0 0 0
Totale 10.565